Brian Burkavage - Net Worth and Insider Trading

Brian Burkavage Net Worth

The estimated net worth of Brian Burkavage is at least $16,445 dollars as of 2024-05-16. Brian Burkavage is the Chief Accounting Officer of IO Biotech Inc and owns about 11,500 shares of IO Biotech Inc (IOBT) stock worth over $16,445. Details can be seen in Brian Burkavage's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian Burkavage has not made any transactions after 2023-11-22 and currently still holds the listed stock(s).

Transaction Summary of Brian Burkavage

To

Brian Burkavage Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Burkavage owns 2 companies in total, including Passage Bio Inc (PASG) , and IO Biotech Inc (IOBT) .

Click here to see the complete history of Brian Burkavage’s form 4 insider trades.

Insider Ownership Summary of Brian Burkavage

Ticker Comapny Transaction Date Type of Owner
PASG Passage Bio Inc 2021-05-30 Controller
IOBT IO Biotech Inc 2023-11-22 Chief Accounting Officer

Brian Burkavage Latest Holdings Summary

Brian Burkavage currently owns a total of 1 stock. Brian Burkavage owns 11,500 shares of IO Biotech Inc (IOBT) as of November 22, 2023, with a value of $16,445.

Latest Holdings of Brian Burkavage

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IOBT IO Biotech Inc 2023-11-22 11,500 1.43 16,445

Holding Weightings of Brian Burkavage


Brian Burkavage Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian Burkavage has made a total of 1 transactions in IO Biotech Inc (IOBT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IO Biotech Inc is the acquisition of 10,000 shares on November 22, 2023, which cost Brian Burkavage around $10,100.

Insider Trading History of Brian Burkavage

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian Burkavage Trading Performance

GuruFocus tracks the stock performance after each of Brian Burkavage's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Burkavage is 40.95%. GuruFocus also compares Brian Burkavage's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Burkavage within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brian Burkavage's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brian Burkavage

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 42.86
Relative Return to S&P 500(%) 38.51

Brian Burkavage Ownership Network

Ownership Network List of Brian Burkavage

No Data

Ownership Network Relation of Brian Burkavage


Brian Burkavage Owned Company Details

What does Passage Bio Inc do?

Who are the key executives at Passage Bio Inc?

Brian Burkavage is the Controller of Passage Bio Inc. Other key executives at Passage Bio Inc include SVP & Interim CFO Kathleen Borthwick , Chief Medical Officer Mark S Forman , and Chief Financial Officer Simona King .

Passage Bio Inc (PASG) Insider Trades Summary

Over the past 18 months, Brian Burkavage made no insider transaction in Passage Bio Inc (PASG). Other recent insider transactions involving Passage Bio Inc (PASG) include a net sale of 13,506 shares made by Simona King , a net sale of 7,772 shares made by Alexandros Fotopoulos , and a net purchase of 1,192,577 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Passage Bio Inc (PASG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 29,386 shares of Passage Bio Inc (PASG) were sold and 1,192,577 shares were bought by its insiders, resulting in a net purchase of 1,163,191 shares.

Passage Bio Inc (PASG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Passage Bio Inc Insider Transactions

No Available Data

Brian Burkavage Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Burkavage. You might contact Brian Burkavage via mailing address: C/o Passage Bio, Inc., One Commerce Square, 39th Floor, Philadelphia Pa 19103.

Discussions on Brian Burkavage

No discussions yet.